BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2652613)

  • 1. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
    McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
    McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
    Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
    Kozaki M; Hirano T; Oka K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
    Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
    [No Abstract]   [Full Text] [Related]  

  • 12. Elective cyclosporine conversion from triple therapy.
    Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
    [No Abstract]   [Full Text] [Related]  

  • 13. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 14. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal graft histology in patients treated with different doses of cyclosporine.
    Wilczek HE; Bohman SO; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
    Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
    [No Abstract]   [Full Text] [Related]  

  • 18. Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
    Kozaki M; Hirano T; Oka K; Honma M; Kang X; Sakurai E; Tamaki T; Tamaki I
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1864-6. PubMed ID: 2652606
    [No Abstract]   [Full Text] [Related]  

  • 19. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.